COVID-19 Convalescent Patient Antibody, RBD Affinity Purified

Products_type

Antibody
Products_short_name

[COVID 19 Coronavirus]
Products_name_syn

[2019 Novel Coronavirus; Coronavirus; CoV; COVID-19 virus; HCoV-2; Human Coronavirus 2019; SARS2; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2]
Products_gene_name

[COVID-19]
Products_gene_name_syn

[2019-nCoV; SARS-CoV-2; SARS coronavirus 2 proteome; COVID19; SARS-CoV2]
Purity

Affinity purification
Form

Lyophilized powder
Concentration

0.01 ml before lyophilization
Storage_stability

-20 C
Tested_application

ELISA (EIA)
Test

A high affinity purification column was use to purify COVID-19 Convalescent Patient Antibody, RBD by MyBioSource by chromatographic size exclusion.
Description

1 of protein A or G purified by MyBioSource will give more specificity than crude serum.
Properties

If you buy Antibodies supplied by MyBioSource they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.
French translation

anticorps

Gene target

COVID-19 Convalescent Patient RBD
Gene symbol

PIRC99, PIRC98, PIRC100, PIRC97, PIRC101
Short name

COVID-19 Convalescent Patient Antibody, RBD
Technique

affinity, Antibody, purified, antibodies against human proteins, antibodies for, purifications
Host

Human serum
Isotype

IgG
Alternative name

COVID-19 Convalescent Patient (antibody to-), RBD protein enriched
Alternative technique

pure, antibodies

Name

Blotting, Western
Concept

Scope note: Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.
Tree numbers
- E05.196.401.143
- E05.301.300.096
- E05.478.566.320.200
- E05.601.262
- E05.601.470.320.200
Qualifiers

ethics, trends, veterinary, history, classification, economics, instrumentation, methods, standards, statistics & numerical data